PharmAust Limited (ASX:PAA – Get Free Report) insider Michael Thurn bought 157,895 shares of the stock in a transaction on Thursday, July 25th. The stock was purchased at an average price of A$0.19 ($0.12) per share, with a total value of A$30,000.05 ($19,607.88).
PharmAust Price Performance
The company has a current ratio of 4.55, a quick ratio of 2.24 and a debt-to-equity ratio of 26.97.
About PharmAust
See Also
- Five stocks we like better than PharmAust
- What is the Shanghai Stock Exchange Composite Index?
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- What is a Dividend King?
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- How to Buy Cheap Stocks Step by Step
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for PharmAust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmAust and related companies with MarketBeat.com's FREE daily email newsletter.